Jules A. Müsing, Former Senior Executive at Johnson & Johnson, Has Been Appointed Chairman of ZyVersa Therapeutics' Board of Directors

Tuesday, May 7, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Mr. Müsing, serving on ZyVersa's Board of Directors for over 2 years, has been instrumental in evolution of the company, and diversification into the large and growing anti-inflammatory market with our novel inflammasome inhibitor targeting ASC



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store